PHIOGEN Trademark
Trademark Overview
On Wednesday, August 31, 2022, a trademark application was filed for PHIOGEN with the United States Patent and Trademark Office. The USPTO has given the PHIOGEN trademark a serial number of 97572922. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, March 19, 2024. This trademark is owned by Baylor College of Medicine. The PHIOGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Therapeutic bacteriophage cocktail compositions; tailored therapeutic phages for drug-resistant bacterial species; biological preparations to treat bacterial infections and bacterial contamination in the field of medicine using bacteriophages; biological preparations for personalized medicine to prevent or treat bacterial infectious diseases using bacteriophages
Development of therapeutic bacteriophage cocktail compositions and related bacteriophage research and development services; pharmaceutical research and development for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders using bacteriophages; pharmaceutical research in the field of engineered bacteriophage; scientific research, namely, research relating to bacteriophage platforms and bacteriophages for use in connection with a wide variety of therapeutic agents; scientific and technical consulting services relating to producing, assaying, and purifying bacteriophages found in humans and animals
General Information
| Serial Number | 97572922 |
| Word Mark | PHIOGEN |
| Filing Date | Wednesday, August 31, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, March 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 25, 2023 |
Trademark Statements
| Goods and Services | Therapeutic bacteriophage cocktail compositions; tailored therapeutic phages for drug-resistant bacterial species; biological preparations to treat bacterial infections and bacterial contamination in the field of medicine using bacteriophages; biological preparations for personalized medicine to prevent or treat bacterial infectious diseases using bacteriophages |
| Goods and Services | Development of therapeutic bacteriophage cocktail compositions and related bacteriophage research and development services; pharmaceutical research and development for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders using bacteriophages; pharmaceutical research in the field of engineered bacteriophage; scientific research, namely, research relating to bacteriophage platforms and bacteriophages for use in connection with a wide variety of therapeutic agents; scientific and technical consulting services relating to producing, assaying, and purifying bacteriophages found in humans and animals |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 19, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 19, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Baylor College of Medicine |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Houston, TX 77030 |
| Party Name | Baylor College of Medicine |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Houston, TX 77030 |
Trademark Events
| Event Date | Event Description |
| Saturday, September 3, 2022 | NEW APPLICATION ENTERED |
| Monday, September 19, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 16, 2023 | ASSIGNED TO EXAMINER |
| Sunday, June 18, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 5, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 25, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 25, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 19, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 19, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, March 19, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, September 4, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| Tuesday, September 17, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, March 20, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 4, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, November 19, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, November 19, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
